28 Followers on Owler
Syntaxin as a biopharmaceutical company focusses on the bacterial-based protein therapeutics for the treatment of chronic diseases... Read more
OverviewCompetitorsFundingNews & Insights
Syntaxin as a biopharmaceutical company focusses on the bacterial-based protein therapeutics for the treatment of chronic diseases... Read more
Syntaxin Ltd. CEO: undefined undefined

CEO

Add

CEO Approval Rating

- -/100

06/2005

PrivateAcquired by Ipsen Pharma

Pharmaceuticals & Biotechnology
PharmaceuticalsMedical Research & Laboratories
28348731 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$61M

Syntaxin Ltd. Competitors

1Vertex Pharmaceuticals
2Chroma Therapeutics
3Bristol-Myers Squibb
4Merck
5Novartis
6AstraZeneca
7Pfizer
8Amgen
9Johnson & Johnson
10Lilly
Unlock 25 + competitors

Trending Companies